Elekta Instrument AB (EKTAF/EKTAF.PK) Wrap Up:

Elekta AB provides clinical solutions for treating cancer and brain disorders worldwide. The company provides image guided radiotherapy clinical solutions in oncology, including linear accelerators, integrated X-ray systems, and clinical solutions. Its oncology products include Elekta Synergy, which integrates three dimensional (3D) imaging in treatment; Elekta Compact, a system for conventional radiotherapy; Elekta VMAT that reduces treatment times; Precise Treatment System, which provides performance parameters for radiation therapy techniques and intensity modulated radiation therapy (IMRT); and Elekta Infinity, a digital linear accelerator for delivering volumetric modulated arc therapy. The company also offers integrated solutions for stereotactic radiosurgery and minimally invasive neurosurgery in treating cancer and brain disorders. Its neuroscience products comprise Gamma Knife surgery Perfexion that provides single pushbutton treatment approach; Elekta Axesse, an integrated stereotactic system combining 3D image guidance in treatment; Leksell Stereotactic System offering an operative system for diagnostic and therapeutic procedures; Elekta Neuromag, a magnetoencephalograph system providing real-time mapping of brain activity by non-invasively measuring resolutions; and SonoWand Invite, an intra-operative imaging system with 3D ultrasound and navigation for brain surgery. In addition, Elekta?s software products consist of MOSAIQ, an image-enabled oncology electronic medical record; XiO, a 3D IMRT treatment planning platform; ERGO++ that provides conformal and IMRT planning for static and rotational beams with specialization in the stereotactic radiosurgery field; Focal 4D, a desktop PC-based distributed planning solution; Monaco, an IMRT-radiation treatment planning system; and Atlas-Based Autosegmentation, an automated contouring application. It serves approximately 5,000 hospitals. The company was founded in 1972 and is headquartered in Stockholm, Sweden.